S C Aitken|M E Lippman - JoVE Visualize

Showing results (161-170 of 269) with videos related to

Pageof 27

Sort By:

The Journal of Steroid Biochemistry and Molecular Biology|February 25, 1999

Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cellsT C Skaar, S C Prasad, S Sharareh, et al.

Cancer Treatment Reports|October 1, 1976

Evaluation of tamoxifen dose in advanced breast cancer: a progress reportD C Tormey, R M Simon, M E Lippman, et al.

Cancer|March 1, 1979

Steroid hormone receptors in human colon cancersT C Alford, H M Do, G W Geelhoed, et al.

Breast Cancer Research and Treatment|March 1, 1995

Hormone dependence of breast cancer cells and the effects of tamoxifen and estrogen: 31P NMR studiesJ Ruiz-Cabello, K Berghmans, O Kaplan, et al.

Cancer Research|October 28, 1999

Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivoC K Tang, X Z Concepcion, M Milan, et al.

Molecular Endocrinology (Baltimore, Md.)|January 1, 1992

Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progressionK J Cullen, M E Lippman, D Chow, et al.

Journal of the National Cancer Institute|February 1, 1982

Vasopressin: action on WRK-1 rat mammary tumor cellsM E Monaco, P H Kohn, W R Kidwell, et al.

FEBS Letters|July 3, 1989

Transformation of mouse mammary epithelial cells with the Ha-ras but not with the neu oncogene results in a gene dosage-dependent increase in transforming growth factor-alpha productionF Ciardiello, N Hynes, N Kim, et al.

Cancer Research|June 13, 2000

Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancerC K Tang, X Q Gong, D K Moscatello, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1993

Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II)N Brünner, D Yee, F G Kern, et al.

Pageof 27

Showing results (161-170 of 269) with videos related to

Sort By:

Pageof 27

The Journal of Steroid Biochemistry and Molecular Biology|February 25, 1999

Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cellsT C Skaar, S C Prasad, S Sharareh, et al.

Cancer Treatment Reports|October 1, 1976

Evaluation of tamoxifen dose in advanced breast cancer: a progress reportD C Tormey, R M Simon, M E Lippman, et al.

Cancer|March 1, 1979

Steroid hormone receptors in human colon cancersT C Alford, H M Do, G W Geelhoed, et al.

Breast Cancer Research and Treatment|March 1, 1995

Hormone dependence of breast cancer cells and the effects of tamoxifen and estrogen: 31P NMR studiesJ Ruiz-Cabello, K Berghmans, O Kaplan, et al.

Cancer Research|October 28, 1999

Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivoC K Tang, X Z Concepcion, M Milan, et al.

Molecular Endocrinology (Baltimore, Md.)|January 1, 1992

Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progressionK J Cullen, M E Lippman, D Chow, et al.

Journal of the National Cancer Institute|February 1, 1982

Vasopressin: action on WRK-1 rat mammary tumor cellsM E Monaco, P H Kohn, W R Kidwell, et al.

FEBS Letters|July 3, 1989

Transformation of mouse mammary epithelial cells with the Ha-ras but not with the neu oncogene results in a gene dosage-dependent increase in transforming growth factor-alpha productionF Ciardiello, N Hynes, N Kim, et al.

Cancer Research|June 13, 2000

Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancerC K Tang, X Q Gong, D K Moscatello, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1993

Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II)N Brünner, D Yee, F G Kern, et al.

Pageof 27